Denmark· DK-28106831622
ORSERDU
A elacestrant product containing elacestrantdihydrochlorid, registered in Denmark by Stemline Therapeutics B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Elacestrant is registered in 14 of 19 countries.
Countries holding a registration under ATC L02BA04 (elacestrant), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Elacestrant · ATC L02BA04
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of elacestrant costs, country by country.
Normalised to the WHO defined daily dose (0.345 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Elacestrant · price per daily dose (0.345 g)
USD · FX 28 Sept 2026
- CH Switzerland$374.12
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Elacestrantdihydrochlorid
- Manufacturer
- Stemline Therapeutics B.V.
- Country
- Denmark (DK)
- ATC code
- L02BA04
- ATC class
- Elacestrant
- Defined daily dose
- 0.345 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106831622
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L02BA04
Elacestrant, as other registers publish it.
- United KingdomKorserdu 345mg tabletsMenarini Stemline UK Ltd
- United KingdomKorserdu 86mg tabletsMenarini Stemline UK Ltd
- PolandOrserduStemline Therapeutics B.V.
- IcelandOrserduStemline Therapeutics B.V.
- PolandOrserduStemline Therapeutics B.V.
- NorwayOrserduStemline
- IcelandOrserduStemline Therapeutics B.V.
- FinlandORSERDUStemline Therapeutics B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dffa871e-53e6-4947-9865-94f8432e9b4f GET /v1/drugs/dffa871e-53e6-4947-9865-94f8432e9b4f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "86 mg",
"auth_role": "MOD",
"dk_drugid": "28106831622",
"substance": "Elacestrantdihydrochlorid",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "45184"
}See everything about elacestrant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.